Please join us at the 28th NIH Tissue Chip Consortium Joint Meeting with the Critical Path Institute’s Complex In Vitro Model Qualification Framework Public Workshop on December 7-8, 2026. Over the past 13 years, the NIH has brought together members of the NIH Tissue Chip Consortium, including funded academic investigators, members of the pharmaceutical industry, and government agencies to accelerate the use, adoption, and ultimately dissemination of tissue chip technology across the United States. This year, NIH has partnered again with C-Path’s Predictive Safety Testing Consortium (PSTC), a recognized global leader in drug development, to put together a joint meeting at no registration cost focused on accelerating the employment of tissue chips within the drug development pipeline. Day 1 (December 7th) will feature the NCATS, NIA, and NIAID MPS program teams, while Day 2 (December 8th) will focus on regulatory considerations, followed by interactive breakout sessions for in-depth discussions on the specifics related to different organ systems and disease models.
Event Details:
This workshop will offer both in-person and virtual attendance options. Please select the format that best reflects how you plan to participate.
In-person space is limited, so we ask that you register for in-person attendance only if you expect to attend onsite. If your plans change, please email the organizers so that your space can be made available to another attendee.
Virtual participation will be available for those unable to attend in person. Please note that recordings of all presentations cannot be guaranteed, and some workshop content may not be available for viewing after the event. In addition, the in-depth breakout sessions on Day 2 will not be recorded.
Attendees who wish to participate fully in these interactive sessions should plan to join in person.
